Happy Thanksgiving from Pioneer Institute!

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

As we welcome the holiday season, I would like to thank you for everything you do with and for Pioneer. We are grateful for your support today and everyday. We are grateful for a nation that has shown incredible resilience in recovering from a global pandemic. For innovation in the life sciences to develop and distribute vaccines. For learning pods, homeschooling, and private and parochial models that have kept our kids engaged, whether in-person or remote. For telehealth and regulatory changes to give patients greater access to medical care. For the MBTA’s commitment to infrastructure investments to improve service for the Bay State’s one million commuters. Lastly, for a business community that has overcome the challenge of extended closures, is now contending with unprecedented labor and supply shortages – and will soon face the threat of a ballot measure that could impose a major state tax increase. With your continued support, Pioneer will remain active on these issues and many more.

As we gather with family and friends this Thanksgiving, I want to encourage our community to be part of bringing our country back together, one dinner table at a time. Let’s remember that political conversations are not taboo, only those long on anger and short on policy substance. Let’s be grateful for the opportunity to be with loved ones, for all we have—and, most of all, for our freedoms.

Happy Thanksgiving,
Jim Stergios, Executive Director

PS – Giving Tuesday is around the corner. If you’d like to get a jump on making your end of year donation, you can do so here!

Recent Posts:

Jean Strouse on J.P. Morgan & the Rise of American Finance

This week on “The Learning Curve,” Gerard Robinson and guest co-host Kerry McDonald talk with Jean Strouse, author of the award-winning biography of J.P. Morgan, Morgan: American Financier. They discuss why the general public and students alike should know more about the life and accomplishments of the controversial, late 19th- and early 20th-century American banker.

Supreme Court Shift: Interpreting Changes in Justices, Majorities, and Philosophies

This week on Hubwonk, host Joe Selvaggi talks with Ilya Shapiro, constitutional scholar, author, and senior fellow of Constitutional Studies at the Manhattan Institute, about the changing makeup of the court, and how this term’s most high-profile decisions reveal the judicial philosophies that comprise the current bench.

Pedro Zamora on Immigrant Entrepreneurs in Kansas City

This week on JobMakers, host Denzil Mohammed talks with Pedro Zamora, executive director of the Hispanic Economic Development Corporation of Greater Kansas City. Pedro and his organization work on initiatives that are crucial to the economic vitality of the area, and they’ve helped more than 4,700 businesses. Immigrants there are having an outsized economic and cultural impact, and so Kansas City is yet another example of how localities can bounce back and benefit from immigrants and refugees, as you’ll learn in this week’s JobMakers podcast.

Mt. Holyoke’s Pulitzer-Winning Prof. Joseph Ellis on John Adams & American Independence

This Fourth of July week on “The Learning Curve," co-hosts Gerard Robinson and Cara Candal talk with Dr. Joseph Ellis, Professor Emeritus of History at Mount Holyoke College and author of the Pulitzer Prize-winning book, Founding Brothers: The Revolutionary Generation.

Survey of Business Sentiment: MA Income Tax Hike Would Lead to Employer Exodus

Nearly three quarters (73 percent) of Massachusetts business leaders think business associates will leave the state if a constitutional amendment appearing on the November ballot to hike taxes is successful, according to a survey conducted by Pioneer Institute.

Drug Cost Disruption: Direct Generic Access Can Save Consumers Billions

Hubwonk host Joe Selvaggi talks with Dr. Hussain Lalani about his recently published research on the potential for more than $3 billion in savings were Medicare to use Mark Cuban’s new direct-to-consumer drug company to purchase generics.